Biotech | February 17, 2022
Kato wins USFDA approval for studies in retinal disorder
Resolv ER may remedy leading causes of blindness in adults
Resolv ER may remedy leading causes of blindness in adults
New data from ongoing trial showed increased antibody response against Beta, Delta, Alpha, Gamma and Omicron variants following third dose booster with Vaxzevria
Only antibody authorised in the US for pre-exposure prophylaxis of COVID-19
Through this initiative, the Centre for Trauma will create curriculums and facilitate trauma-related courses for healthcare professionals at both urban and grassroot levels
A treatment to prevent extreme symptoms and cut hospitalisation
The companies anticipate clinical studies to begin in August, subject to regulatory approvals
he innovation could pave the way for early and low-cost screening of smoking exposure and second-hand smoke biomarkers
The CE Mark builds on the company’s ISO 13485 certification, further strengthening confidence in the platform's safety, quality and performance
Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments
The upcoming multi-center, multinational Phase 1 study will evaluate safety, tolerability, pharmacokinetics, and early signs of efficacy
Subscribe To Our Newsletter & Stay Updated
